Stay updated on BMS-986226 Immunotherapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986226 Immunotherapy Combo Clinical Trial page.

Latest updates to the BMS-986226 Immunotherapy Combo Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating the study record is inaccessible due to an access issue or server restriction. This represents an access/availability problem rather than an update to the study data.SummaryDifference20%

- Check65 days agoChange DetectedAdded the 2017 NIH grant/contract note and updated the revision tag to v3.6.6, while the previous revision tag v3.6.5 was removed.SummaryDifference0.1%

Stay in the know with updates to BMS-986226 Immunotherapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986226 Immunotherapy Combo Clinical Trial page.